91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Dr. Caroline Forkin, VP Clinical Research Services, considers .
This article is taken from European Biopharmaceutical Review October 2021, pages 70-73. Samedan Ltd
-
Dr. Greg Licholai, Chief Medical Information Officer, discusses .
-
Isaac R Rodriguez-Chavez contributes to the newsletter, discussing the use of digital health to maximise efficiencies in decentralised clinical trials.
-
, including the increasing adoption of decentralised clinical trials (DCTs) and the growing use of remote monitoring to collect data.
-
This article discusses .
-
Top 10 factors to design and deploy a decentralised clinical trial
Dr. Isaac Rodriguez-Chavez considers the top 10 factors when designing and deploying a decentralised clinical trial.
This article is taken from International Clinical Trials August 2021, pages 8-10. Samedan Ltd.
-
John Macdonald, Vice President, Venture & Financial Alliances, examines – its expertise and opportunities, and potential for growth.
-
William Maier, VP Rare Diseases, Drug Development Sciences, considers .
-
Chris O'Toole, VP Commercial Solutions, discusses .
-
Dr. Brian Huber outlines the role biomarkers play in guiding therapeutic strategies.
